Detailed Narrative
Impact of Expired Enhanced Premium Tax Credits
The expiration of enhanced premium tax credits led to a significant and worse-than-expected payer mix shift, with adjusted admissions for former exchange patients declining by 15%. This resulted in an almost one-for-one migration to uninsured status, impacting adjusted EBITDA by approximately $400 million in Q2 FY26. Three divisions (Gulf Coast, North Florida, South Atlantic) accounted for about 50% of this impact, experiencing 25-28% declines in HICS adjusted admissions. The full-year 2026 estimated impact on adjusted EBITDA from health insurance exchanges is now negative $1 billion to $1.2 billion.
Volume Trends and Surgical Performance
Despite the challenging payer mix shift, insured volumes (excluding exchanges) increased by 3.2% in Q2 FY26 and 2.2% year-to-date, driven by solid trends in ER visits (+3.6%), cardiac procedures, and rehab volumes. However, inpatient surgeries were down 2.3% and outpatient surgeries down 3.4% in Q2. Elective surgeries, particularly, saw declines (inpatient elective down 6% YTD), partly attributed to HICS demand and general economic affordability pressures. Emergency inpatient surgeries, representing two-thirds of inpatient cases, were up 2% year-over-year.
Medicaid Supplemental Payment Programs
HCA recognized approximately $400 million of incremental net benefit from Medicaid supplemental payment programs in Q2 FY26. This included a $540 million incremental net benefit related to the recently approved Florida program, covering the period from October 1, 2024, to June 30, 2026. This benefit was partially offset by retro payments received in Q2 FY25. The full-year 2026 guidance for Medicaid supplemental payment net benefit is $300 million to $500 million, implying a $100 million to $300 million headwind in H2 FY26.
Financial Resiliency Program and Cost Management
The company is advancing a long-term, multifaceted financial resiliency program focused on digital transformation, global capabilities, and enhanced workforce development. This program contributed to cost improvements, with same-facility cost per equivalent admission (considering Medicaid supplemental payment programs) essentially flat year-over-year in Q2 FY26 and improving 1.4% sequentially. Management is confident this program will continue to improve cost trends in H2 FY26 and into 2027, producing multi-year benefits.
Capital Allocation and Capacity Expansion
HCA has approved over $7 billion in capital expenditures for the next three years, aimed at increasing capacity and improving competitive positioning. This includes adding 1,000 to 1,200 inpatient beds and 250-300 new outpatient facilities, which will add approximately 10% to the overall network capacity. The company's total sites of care increased by 5% year-over-year in Q2 FY26. These investments are supported by positive demographic trends in HCA's key markets, which are expected to drive long-term demand growth of 2-3%.
Medicaid Work Requirements and Future Outlook
Management is monitoring proposed Medicaid work requirements, anticipating a greater impact in expansion states, where 40% of HCA's Medicaid revenues originate. While acknowledging potential impacts, HCA believes it can manage through these changes by leveraging its coverage benefit support teams and strategic asset distribution. For 2027, the company estimates that coverage loss from exchanges will be less than in 2026, assuming no new enhanced premium support, as the primary driver of 2026 attrition (expiration of enhanced premium tax credits) will have passed.